Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Rockwell Medical (RMTI) Accumulated Depreciation & Amortization (2016 - 2025)

Rockwell Medical's Accumulated Depreciation & Amortization history spans 15 years, with the latest figure at $2.2 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 0.55% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $2.2 million, up 0.55%, while the annual FY2025 figure was $2.2 million, 0.55% up from the prior year.
  • Accumulated Depreciation & Amortization reached $2.2 million in Q4 2025 per RMTI's latest filing, up from $1.6 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $2.2 million in Q4 2025 to a low of $138000.0 in Q1 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is $848400.0, with a median of $560500.0 recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: plummeted 31.68% in 2022, then surged 240.62% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $668000.0 in 2021, then fell by 13.77% to $576000.0 in 2022, then skyrocketed by 150.69% to $1.4 million in 2023, then skyrocketed by 50.97% to $2.2 million in 2024, then grew by 0.55% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Accumulated Depreciation & Amortization are $2.2 million (Q4 2025), $1.6 million (Q3 2025), and $1.1 million (Q2 2025).